Spruce Biosciences (SPRB) Other Non-Current Liabilities (2019 - 2026)
Spruce Biosciences' Other Non-Current Liabilities came in at $3.32 million for Q2 2026, down 15.6% from the prior quarter.
Powered by 
Analysis
Spruce Biosciences (SPRB) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2024, Spruce Biosciences' Other Non-Current Liabilities was $282,000, up 19.5% from FY2023.
- Other Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 69.8% (FY2019 to FY2024).
- Going back by year, Other Non-Current Liabilities was $236,000 in FY2023 (+46.6%), $161,000 in FY2022 (+120.5%), $73,000 in FY2021 (-38.1%) and $118,000 in FY2020 (+490.0%).
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Liabilities since Q4 2024.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2022 (growth of 303.4%), and the weakest in Q3 2021 (a decline of 46.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Spruce Biosciences | 103.09 Mn | -106.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2024 | 282,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 236,000.00 |
| Sep 30, 2023 | 220,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 181,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 139,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 95,000.00 |
| Dec 31, 2021 | 73,000.00 |
| Sep 30, 2021 | 51,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 8,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 95,000.00 |
API Access
Spruce Biosciences Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SPRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();